Meta-analysis of comparison of IVB and IVR used for retinopathy of prematurity

Meta-analysis of comparison of IVB and IVR used for retinopathy of prematurity

AIM: To evaluate the effectiveness of intravitreal bevacizumab(IVB)and ranibizumab(IVR)for the treatment of type 1 retinopathy of prematurity(ROP)by Meta-analysis.METHODS: The PubMed, Embase, Web of Science, the Cochrane Library, CNKI, CQVIP, CBM, OVID and Wanfang were systematically searched. All c...

Full description

Bibliographic Details
Main Authors:	Rong-Xia Cao, Yan-Jie Li, Wei-Shai Liu, Zi-Chao Bai, Liu-Sen Yang, Xian Li
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2021-03-01
Series:	Guoji Yanke Zazhi
Subjects:	retinopathy of prematurity bevacizumab ranibizumab meta-analysis systematic review
Online Access:	http://ies.ijo.cn/cn_publish/2021/3/202103022.pdf

Similar Items

Axial length, refraction, and retinal vascularization 1 year after ranibizumab or bevacizumab treatment for retinopathy of prematurity
by: Lin CJ, et al.
Published: (2016-07-01)

Evaluating peripheral retinal vascularization and rate of recurrence after intravitreal injection of ranibizumab as a primary treatment for retinopathy of prematurity
by: Mostafa M El Manhaly, et al.
Published: (2020-01-01)

Pharmacological Approach for Treatment of Retinopathy of Prematurity
by: İmren Akkoyun
Published: (2012-12-01)

Clinical report of intravitreal Bevacizumab for 26 cases with retinopathy of prematurity in Zone Ⅰ
by: Feng Chen, et al.
Published: (2016-07-01)

Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
by: Xiu-Juan Li, et al.
Published: (2016-01-01)

Clinical observation of Ranibizumab on retinopathy of prematurity with or without preretinal hemorrhage
by: Qin Peng, et al.
Published: (2021-02-01)

Effect of anti-VEGF treatment on retinopathy of prematurity in Zone II Stage 3+
by: Xiu-Mei Yang, et al.
Published: (2018-04-01)

Bevacizumab or laser for aggressive posterior retinopathy of prematurity
by: Michael Blair, et al.
Published: (2018-01-01)

Evidence to date: ranibizumab and its potential in the treatment of retinopathy of prematurity
by: Patel SN, et al.
Published: (2019-08-01)

Fluorescein angiography of retinal vascular involution after intravitreal injection of ranibizumab for retinopathy of prematurity
by: Yong Cheng, et al.
Published: (2019-01-01)

Experimental histopathological study on retinal and renal cellular response to intravitreous antiangiogenic drugs
by: João Borges Fortes Filho, et al.
Published: (2014-06-01)

Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
by: Obata S, et al.
Published: (2019-12-01)

Review of effects of anti-VEGF treatment on refractive error
by: Mintz-Hittner HA, et al.
Published: (2016-06-01)

Post-Ranibizumab injection endophthalmitis in aggressive posterior retinopathy of prematurity
by: Parijat Chandra, et al.
Published: (2019-01-01)

Outcomes of early versus deferred laser after intravitreal ranibizumab in aggressive posterior retinopathy of prematurity
by: Anil Babanrao Gangwe, et al.
Published: (2021-01-01)

The process of retinal vascularization in retinopathy of prematurity after ranibizumab treatment in China
by: Qing-Yu Meng, et al.
Published: (2019-07-01)

Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
by: Ágata Mota, et al.
Published: (2012-04-01)

Application of quadrant classification in infants with threshold and type 1 prethreshold stage retinopathy of premature
by: Qiu-Ping Liu, et al.
Published: (2020-10-01)

Intravitreal bevacizumab (Avastin) for post laser anterior segment ischemia in aggressive posterior retinopathy of prematurity
by: Shah Parag, et al.
Published: (2007-01-01)

Ocular and Systemic Results of Intravitreal Bevacizumab Injection in Retinopathy of Prematurity Treatment
by: Sadik Gorkem Cevik, et al.
Published: (2020-08-01)

Effect of two different doses of intravitreal bevacizumab with temporal retina-sparing laser photocoagulation for retinopathy of prematurity
by: A Young Choi, et al.
Published: (2018-01-01)

Laser therapy versus intravitreal injection of anti-VEGF agents in monotherapy of ROP: a Meta-analysis
by: Shi-Dan Wang, et al.
Published: (2020-05-01)

Prevalence of retinopathy of prematurity in Iran: asystematic review and Meta-analysis
by: Saman Maroufizadeh, et al.
Published: (2017-08-01)

Intravitreal bevacizumab as rescue therapy following treatment failure with laser photocoagulation in retinopathy of prematurity
by: Caner Kara, et al.
Published: (2018-03-01)

The efficacy of intravitreal antivascular endothelial growth factor as primary treatment of retinopathy of prematurity: Experience from a tertiary hospital
by: H Kana, et al.
Published: (2017-03-01)

Clinical effect of laser photocoagulation combined with minimal doses of intravitreal Ranibizumab for aggressive posterior retinopathy of prematurity
by: He Cao, et al.
Published: (2019-11-01)

Macular hole following successful stage 4B/stage 5 retinopathy of prematurity surgery
by: Ekta Rishi, et al.
Published: (2019-01-01)

ANGIOGENESIS IN PROLIFERATIVE DIABETIC RETINOPATHY: RERSPECTIVES OF ANTI-VEGF THERAPY (REVIEW OF LITERATURE)
by: V. I. Konenkov, et al.
Published: (2015-12-01)

Intravitreal ranibizumab as salvage therapy in an extremely low-birth-weight infant with rush type retinopathy of prematurity
by: Chun-Ju Lin, et al.
Published: (2012-01-01)

Vitreous changes after intravitreal bevacizumab monotherapy for retinopathy of prematurity: a case series
by: Nasser Shoeibi, et al.
Published: (2018-03-01)

Anatomic outcomes of laser indirect ophthalmoscopy for retinopathy of prematurity in a tertiary referral center in the Philippines
by: David Francis Fullon Chan, et al.
Published: (2019-05-01)

Bevacizumab treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity
by: Fei Feng, et al.
Published: (2014-08-01)

Anti-VEGF and laser therapy for type 1 retinopathy of prematurity: a Meta analysis
by: Qi Xiong, et al.
Published: (2021-02-01)

Profile of asymmetrical retinopathy of prematurity in twins
by: Azad Rajvardhan, et al.
Published: (2010-01-01)

Outcomes and prognostic factors for aggressive posterior retinopathy of prematurity following initial treatment with intravitreal ranibizumab
by: Qizhe Tong, et al.
Published: (2018-06-01)

Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
by: Fouzdar Jain S, et al.
Published: (2018-05-01)

Aggressive Posterior Retinopathy of Prematurity in a Premature Male Infant
by: Jun Zhou, et al.
Published: (2017-07-01)

Retinopathy of prematurity-An overview
by: Natasha Radhakrishnan, et al.
Published: (2017-01-01)

Usefulness of Intravitreal Bevacizumab for Retinopathy of Prematurity with Severely Dilated Tunica Vasculosa Lentis and Poor Mydriasis
by: Tomoaki Higashiyama, et al.
Published: (2017-03-01)

Intravitreal Injection of Bevacizumab for Retinopathy of Prematurity in an Infant with Peters Anomaly
by: Tsuyoshi Minami, et al.
Published: (2014-10-01)